A multi-centre phase IIa clinical study of predictive testing for preeclampsia: Improved pregnancy outcomes via early detection (IMPROvED)

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Navaratnam, Kate ^a   Alfirevic, Zarko ^a   Baker, Philip N ^b   Gluud, Christian ^c   Grüttner, Berthold ^d   Kublickiene, Karolina ^e   Zeeman, Gerda ^f   Kenny, Louise C ^g  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c Copenhagen Trial Unit ^*  (Denmark)

^d UNIVERSITY OF COLOGNE   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^g UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Metabolomics; Pre eclampsia; Preterm birth; Proteomics; Screening; Small for gestational age

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; METABOLOMICS; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHLEBOTOMY; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANCY TEST; PROTEOMICS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMANS; METABOLOMICS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROTEOMICS; RESEARCH DESIGN;

EID: 84889059279     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-226     Document Type: Article

References (14)

1. Lanzieri G. First demographic estimates for 2009. Eurostat 2009, Eurostat, European Union, http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-QA-09-047/EN/KS-QA-09-047-EN.PDF.
2. Wildman K, Bouvier-Colle M. Maternal mortality as an indicator of obstetric care in Europe. Br J Obstet Gynaecol 2004, 111(2):164-169.
3. Valdés G, Quezada F, Marchant E, von Schultzendorff A, Morán S, Padilla O. Association of remote hypertension in pregnancy with coronary artery disease: a case-control study. Hypertension 2009, 53(4):733-738. 10.1161/HYPERTENSIONAHA.108.127068, 19204177.
4. Vikse B, Irgens L, Leivestad T, Skjaerven R, Iversen B. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008, 359(8):800-809. 10.1056/NEJMoa0706790, 18716297.
5. Barker D. Fetal origins of coronary heart disease. Br Med J 1995, 311(6998):171-174.
6. Meads C, Cnossen J, Meher S, Juarez-Garcia A, ter Riet G, Duley L. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008, 12(6):1-270.
7. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010, 116(2 pt 1):402-414.
8. Myers J, Hart S, Armstrong S, Mires G, Beynon R, Gaskell S. Evidence for multiple circulating factors in preeclampsia. Am J Obstet Gynecol 2007, 196(3):266. e261-266.
9. Grill S, Rusterholz C, Zanetti-Dallenbach R, Tercanli S, Holzgreve W, Hahn S. Potential markers of preeclampsia-a review. Reprod Biol Endocrinol 2009, 7:70-75. 10.1186/1477-7827-7-70, 2717076, 19602262.
10. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004, 104(6):1367-1391. 10.1097/01.AOG.0000147599.47713.5d, 15572504.
11. Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA, McCowan L, Roberts C, Cooper GJ, Kell DB, Baker PN. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 2010, 56(4):741-749. 10.1161/HYPERTENSIONAHA.110.157297, 20837882.
12. Myers JETR, Thomas G, Laroy W, Kas K, Vanpoucke G, Roberts CT, Kenny LC, Simpson NA, Baker PN, North RA. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia. Hypertension 2013, 61(6):1281-1288. 10.1161/HYPERTENSIONAHA.113.01168, 23547239.
13. Smith G. First-trimester determination of complications of late pregnancy. JAMA 2010, 303:561-562. 10.1001/jama.2010.102, 20145237.
14. Smith G. Researching new methods of screening for adverse pregnancy outcome: lessons from pre-eclampsia. PLoS Med 2012, 9:e1001274. 10.1371/journal.pmed.1001274, 3409135, 22859910.